ArticleBiomaterials2023

A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.

Suhaila O Alhaj-Suliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.